Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Select Investment Series III SICAV - T. Rowe Price Health Science Equity Fund Q Fonds 113766580 / LU2349435961

8.91 USD
-0.02 USD
-0.22 %
3.1.2025
NAV

Nettoinventarwert (NAV)

8.91 USD -0.02 USD -0.22 %
Vortag 8.93 USD Datum 03.01.2025

Select Investment Series III SICAV - T. Rowe Price Health Science Equity Fund Q Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 367.15%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Stellar ETP CH1109575535 216.44%
21Shares Cardano ETP CH1102728750 207.61%
21Shares Sui Staking ETP CH1360612159 144.26%
21Shares Aave ETP CH1135202120 134.46%
21Shares Injective Staking ETP CH1360612134 10.65%
21Shares Immutable ETP CH1360612142 -11.92%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 475.30%
21Shares Aave ETP CH1135202120 332.51%
21Shares Stellar ETP CH1109575535 244.32%
21Shares Cardano ETP CH1102728750 209.77%
21Shares Stacks Staking ETP CH1258969042 145.10%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 323.11%
21Shares Aave ETP CH1135202120 232.41%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 181.47%
21Shares Stellar ETP CH1109575535 144.11%
21Shares Crypto Mid-Cap Index ETP CH1130675676 131.62%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’596.10%
21Shares Ripple XRP ETP CH0454664043 585.99%
21Shares Aave ETP CH1135202120 494.88%
21Shares Bitcoin Core ETP CH1199067674 476.42%
21Shares Bitcoin ETP CH0454664001 461.88%

Fundamentaldaten

Valor 113766580
ISIN LU2349435961
Emittent T. Rowe Price Management
Aufgelegt in Luxembourg
Auflagedatum 08.11.2021
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 223’023’311.44
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 31.12.
Berichtsstand 06.01.2025

Anlagepolitik

So investiert der Select Investment Series III SICAV - T. Rowe Price Health Science Equity Fund Q Fonds: To increase the value of its shares, over the long term, through growth in the value of, and income from, its investments. The fund is actively managed and invests mainly in a diversified portfolio of shares of companies that are involved in the research, development, production, or distribution of products or services related to health sciences. The companies may be anywhere in the world, including emerging markets, with a focus on companies in the United States.

ETP Performance: Select Investment Series III SICAV - T. Rowe Price Health Science Equity Fund Q Fonds

Performance 1 Jahr
2.30
Performance 2 Jahre
8.13
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -